University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Jennifer Cocohoba, Pharm.D.

Pharmacist

Jennifer Cocohoba is a clinical pharmacist for the Women's HIV Program at UCSF Medical Center. She provides training and education to help patients better adhere to their medications. She assists staff with medication-related questions, selection of antiretrovirals and other drug therapy, and interpretation of antiretroviral resistance tests.

Cocohoba's research interests include antiretroviral pharmacoepidemiology, treatment disparities and designing interventions to increase uptake and adherence to HIV antiretrovirals.

Cocohoba earned a doctor of pharmacy degree and completed a pharmacy practice residency at UCSF, then a specialty residency in HIV/AIDS ambulatory care at San Francisco General Hospital before joining the faculty in 2003. She is currently an associate clinical professor in the Department of Clinical Pharmacy, UCSF School of Pharmacy.

Clinics

HIV/AIDS Program
350 Parnassus Avenue, Suite 908
San Francisco, CA 94143
Phone: (415) 353-2119
Fax: (415) 353-2406

Hours: Monday to Thursday
8:30 a.m. – noon, 1 – 5 p.m.

Conditions & Treatments

More about Jennifer Cocohoba

Education

UCSF School of Pharmacy 2001

Residencies

UCSF Medical Center 2002

Selected Research and Publications

  1. Cook JA, Burke-Miller JK, Grey DD, Cocohoba J, Liu C, Schwartz RM, Golub ET, Anastos K, Steigman PJ, Cohen MH. Do HIV-Positive Women Receive Depression Treatment that Meets Best Practice Guidelines? AIDS Behav. 2014 Jun; 18(6):1094-102.
  2. Hanna DB, Hessol NA, Golub ET, Cocohoba JM, Cohen MH, Levine AM, Wilson TE, Young M, Anastos K, Kaplan RC. Increase in Single-Tablet Regimen Use and Associated Improvements in Adherence-Related Outcomes in HIV-Infected Women. J Acquir Immune Defic Syndr. 2014 Apr 15; 65(5):587-96.
  3. Cocohoba J, Dong BJ, Johnson MO, Saberi P. Reporting of critical information in studies of pharmacists in HIV care. Int J Pharm Pract. 2014 Dec; 22(6):375-85.
  4. Cocohoba J, Comfort M, Kianfar H, Johnson MO. A qualitative study examining HIV antiretroviral adherence counseling and support in community pharmacies. J Manag Care Pharm. 2013 Jul-Aug; 19(6):454-60.
  5. Cocohoba JM, Murphy P, Pietrandoni G, Guglielmo BJ. Improved antiretroviral refill adherence in HIV-focused community pharmacies. J Am Pharm Assoc (2003). 2012 Sep-Oct; 52(5):e67-73.
  6. Murphy P, Cocohoba J, Tang A, Pietrandoni G, Hou J, Guglielmo BJ. Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy. AIDS Patient Care STDS. 2012 Sep; 26(9):526-31.
  7. Cocohoba JM, Althoff KN, Cohen M, Hu H, Cunningham CO, Sharma A, Greenblatt RM. Pharmacist counseling in a cohort of women with HIV and women at risk for HIV. Patient Prefer Adherence. 2012; 6:457-63.
  8. Saberi P, Dong BJ, Johnson MO, Greenblatt RM, Cocohoba JM. The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review. Patient Prefer Adherence. 2012; 6:297-322.
  9. Sherman EM, Cocohoba JM, Neff SE, Dong BJ. Health care provider satisfaction with telephone consultations provided by pharmacists and physicians at the National HIV/AIDS Clinicians' Consultation Center. Ann Pharmacother. 2011 Dec; 45(12):1499-505.
  10. Cocohoba J. Making sense of side effects. BETA. 2011 Fall-Winter; 23(4):19-29.
  11. Cocohoba JM, Althoff KN, Godfrey R, Palella FJ, Greenblatt RM. Influence of gender on receipt of guideline-based antiretroviral therapy in the era of HAART. AIDS Care. 2012; 24(1):20-9.
  12. Lao CK, Gruta C, John MD, Cocohoba J. A comparison of tenofovir-associated renal function changes in HIV-infected African Americans vs Caucasians. J Natl Med Assoc. 2011 Jun; 103(6):518-22.
  13. Yi T, Cocohoba J, Cohen M, Anastos K, DeHovitz JA, Kono N, Hanna DB, Hessol NA. The impact of the AIDS Drug Assistance Program (ADAP) on use of highly active antiretroviral and antihypertensive therapy among HIV-infected women. J Acquir Immune Defic Syndr. 2011 Mar 1; 56(3):253-62.
  14. Cocohoba J. Hormonal contraception for HIV positive women. BETA. 2010 Winter-Spring; 22(2):36-40.
  15. Cocohoba J. The SWITCHMRK studies: substitution of lopinavir/ritonavir with raltegravir in HIV-positive individuals. Expert Rev Anti Infect Ther. 2009 Dec; 7(10):1159-63.
  16. Cocohoba J, Dong BJ. Raltegravir: the first HIV integrase inhibitor. Clin Ther. 2008 Oct; 30(10):1747-65.
  17. Cocohoba J, Ramay B, Patterson S. HIV postexposure prophylaxis availability in U.S. rural hospitals. Am J Health Syst Pharm. 2008 Oct 1; 65(19):1796-7.
  18. El-Ibiary SY, Cocohoba JM. Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives. Eur J Contracept Reprod Health Care. 2008 Jun; 13(2):123-32.
  19. Cocohoba J, Wang QJ, Cox C, Gange SJ, Cohen M, Glesby M, DeHovitz JA, Greenblatt RM. Consistency of initial antiretroviral therapy with HIV treatment guidelines in a US cohort of HIV-infected women. J Acquir Immune Defic Syndr. 2008 Mar 1; 47(3):377-83.
  20. Robinson CA, Cocohoba J, MacDougall C, John MD, Guglielmo BJ. Discordance between ambulatory care clinic and community pharmacy medication databases for HIV-positive patients. J Am Pharm Assoc (2003). 2007 Sep-Oct; 47(5):613-5.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.